Cargando…

Nitroheterocyclic drugs cure experimental Trypanosoma cruzi infections more effectively in the chronic stage than in the acute stage

The insect-transmitted protozoan parasite Trypanosoma cruzi is the causative agent of Chagas disease, and infects 5–8 million people in Latin America. Chagas disease is characterised by an acute phase, which is partially resolved by the immune system, but then develops as a chronic life-long infecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Francisco, Amanda Fortes, Jayawardhana, Shiromani, Lewis, Michael D., White, Karen L., Shackleford, David M., Chen, Gong, Saunders, Jessica, Osuna-Cabello, Maria, Read, Kevin D., Charman, Susan A., Chatelain, Eric, Kelly, John M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066210/ https://www.ncbi.nlm.nih.gov/pubmed/27748443 http://dx.doi.org/10.1038/srep35351

Ejemplares similares

Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly Sensitive In Vivo Imaging
por: Francisco, Amanda Fortes, et al.
Publicado: (2015)

Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development
por: Moraes, Carolina B., et al.
Publicado: (2014)

Synergic Effect of Allopurinol in Combination with Nitroheterocyclic Compounds against Trypanosoma cruzi
por: Mazzeti, Ana Lia, et al.
Publicado: (2019)

Host and parasite genetics shape a link between Trypanosoma cruzi infection dynamics and chronic cardiomyopathy
por: Lewis, Michael D., et al.
Publicado: (2016)

Nitroheterocyclic drug resistance mechanisms in Trypanosoma brucei
por: Wyllie, Susan, et al.
Publicado: (2016)

Intracellular DNA replication and differentiation of Trypanosoma cruzi is asynchronous within individual host cells in vivo at all stages of infection
por: Taylor, Martin C., et al.
Publicado: (2020)

Comparing in vivo bioluminescence imaging and the Multi-Cruzi immunoassay platform to develop improved Chagas disease diagnostic procedures and biomarkers for monitoring parasitological cure
por: Francisco, Amanda Fortes, et al.
Publicado: (2022)

Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protection
por: Mann, Gurdip Singh, et al.
Publicado: (2020)

In Vivo Analysis of Trypanosoma cruzi Persistence Foci at Single-Cell Resolution
por: Ward, Alexander I., et al.
Publicado: (2020)

Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice
por: Jayawardhana, Shiromani, et al.
Publicado: (2023)

Expanding the toolbox for Trypanosoma cruzi: A parasite line incorporating a bioluminescence-fluorescence dual reporter and streamlined CRISPR/Cas9 functionality for rapid in vivo localisation and phenotyping
por: Costa, Fernanda Cristina, et al.
Publicado: (2018)

Exoproteome profiling of Trypanosoma cruzi during amastigogenesis early stages
por: Mandacaru, Samuel C., et al.
Publicado: (2019)

Inhibition of DNA synthesis by nitroheterocycles. II. Mechanisms of cytotoxicity.
por: Olive, P. L.
Publicado: (1979)

Biophysical and Biochemical Comparison of Extracellular Vesicles Produced by Infective and Non-Infective Stages of Trypanosoma cruzi
por: Retana Moreira, Lissette, et al.
Publicado: (2021)

The steady-state transcriptome of the four major life-cycle stages of Trypanosoma cruzi
por: Minning, Todd A, et al.
Publicado: (2009)

Cysteine Protease Inhibitors Cure an Experimental Trypanosoma cruzi Infection
por: Engel, Juan C., et al.
Publicado: (1998)

Proteomic and network analysis characterize stage-specific metabolism in Trypanosoma cruzi
por: Roberts, Seth B, et al.
Publicado: (2009)

Early Immune Response Elicited by Different Trypanosoma cruzi Infective Stages
por: Gutierrez, Brenda Celeste, et al.
Publicado: (2021)

Further Investigations of Nitroheterocyclic Compounds as Potential Antikinetoplastid Drug Candidates
por: García-Estrada, Carlos, et al.
Publicado: (2023)

Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruzi
por: Brand, Stephen, et al.
Publicado: (2017)

Nuclear Compartmentalization Contributes to Stage-Specific Gene Expression Control in Trypanosoma cruzi
por: Pastro, Lucía, et al.
Publicado: (2017)

Location and expression kinetics of Tc24 in different life stages of Trypanosoma cruzi
por: Versteeg, Leroy, et al.
Publicado: (2021)

Genotoxicity Revaluation of Three Commercial Nitroheterocyclic Drugs: Nifurtimox, Benznidazole, and Metronidazole
por: Buschini, Annamaria, et al.
Publicado: (2009)

Transcriptional and phenotypical heterogeneity of Trypanosoma cruzi cell populations
por: Seco-Hidalgo, Víctor, et al.
Publicado: (2015)

Expression and subcellular localization of kinetoplast-associated proteins in the different developmental stages of Trypanosoma cruzi
por: Cavalcanti, Danielle Pereira, et al.
Publicado: (2009)

Validation of N-myristoyltransferase as Potential Chemotherapeutic Target in Mammal-Dwelling Stages of Trypanosoma cruzi
por: Herrera, Linda J., et al.
Publicado: (2016)

Modulatory Effect of Trypanosoma cruzi Infective Stages in Different Dendritic Cell Populations in vitro
por: Gutierrez, Brenda Celeste, et al.
Publicado: (2020)

The Complete Mitochondrial DNA of Trypanosoma cruzi: Maxicircles and Minicircles
por: Callejas-Hernández, Francisco, et al.
Publicado: (2021)

Th17 Cells Are More Protective Than Th1 Cells Against the Intracellular Parasite Trypanosoma cruzi
por: Cai, Catherine W., et al.
Publicado: (2016)

Inhibition of DNA synthesis by nitroheterocycles. I. Correlation with half-wave reduction potential.
por: Olive, P. L.
Publicado: (1979)

Trypanosoma cruzi alkaline 2-DE: Optimization and application to comparative proteome analysis of flagellate life stages
por: Magalhães, Adriana D, et al.
Publicado: (2008)

SUMOylation of Paraflagellar Rod Protein, PFR1, and Its Stage-Specific Localization in Trypanosoma cruzi
por: Annoura, Takeshi, et al.
Publicado: (2012)

Role of cyclooxygenase-2 in Trypanosoma cruzi survival in the early stages of parasite host-cell interaction
por: Moraes, Karen CM, et al.
Publicado: (2015)

Fatty acid oxidation participates in resistance to nutrient-depleted environments in the insect stages of Trypanosoma cruzi
por: Souza, Rodolpho Ornitz Oliveira, et al.
Publicado: (2021)

Heteroleptic Oxidovanadium(V) Complexes with Activity against Infective and Non-Infective Stages of Trypanosoma cruzi
por: Scalese, Gonzalo, et al.
Publicado: (2021)

TcTASV-C, a Protein Family in Trypanosoma cruzi that Is Predominantly Trypomastigote-Stage Specific and Secreted to the Medium
por: Bernabó, Guillermo, et al.
Publicado: (2013)

Cardiac Manifestations of Trypanosoma cruzi Infection in a Domestic Dog
por: Stoner, Caitlin H., et al.
Publicado: (2020)

Assessing the Effectiveness of Curative Benznidazole Treatment in Preventing Chronic Cardiac Pathology in Experimental Models of Chagas Disease
por: Francisco, Amanda Fortes, et al.
Publicado: (2018)

Development of an Aptamer-Based Concentration Method for the Detection of Trypanosoma cruzi in Blood
por: Nagarkatti, Rana, et al.
Publicado: (2012)

A Novel Trypanosoma cruzi Protein Associated to the Flagellar Pocket of Replicative Stages and Involved in Parasite Growth
por: Durante, Ignacio M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tug8v65hcdi6786bnu8c5rp2kd